Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Argus Health
Daiichi Sankyo
Farmers Insurance
US Army
Johnson and Johnson

Generated: July 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 202402

« Back to Dashboard

NDA 202402 describes IBUPROFEN LYSINE, which is a drug marketed by Exela Pharma Science and is included in one NDA. It is available from one supplier. Additional details are available on the IBUPROFEN LYSINE profile page.

The generic ingredient in IBUPROFEN LYSINE is ibuprofen lysine. There are sixty-four drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the ibuprofen lysine profile page.
Summary for 202402
Applicant:Exela Pharma Science
Ingredient:ibuprofen lysine
Formulation / Manufacturing:see details
Pharmacology for NDA: 202402
Suppliers and Packaging for NDA: 202402
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
IBUPROFEN LYSINE ibuprofen lysine INJECTABLE;INTRAVENOUS 202402 ANDA X-GEN Pharmaceuticals, Inc. 39822-1030 N 39822-1030-2

Profile for product number 001

Approval Date:Mar 30, 2016TE:APRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
Chinese Patent Office
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.